Following news that started brewing last week, Dr Marty Makary has officially resigned from his post as commissioner of the US Food and Drug Administration (FDA), with Kyle Diaman ...

J&J has globally launched its Shockwave C2 Aero coronary IVL catheter, which aims to help in the treatment of calcified CAD.

The US Food and Drug Administration (FDA) has cleared Bayesian Health’s continuous artificial intelligence (AI)-driven sepsis monitor, making the device the first of its kind to ...

HeartBeam has commenced a pilot study to evaluate its on-demand 12-lead ECG patch in patients with suspected coronary artery disease.

The CoMira Diagnostics JV has completed a lease agreement for its planned manufacturing facility in Sudair Industrial City, Saudi Arabia.

According to a report by Barnes & Thornburg, the Department of Justice (DoJ) is clamping down on fraud across the healthcare industry.

Ahead of Biomed Israel, Chaim Lotan discusses how innovation in cardiovascular medicine is evolving toward more precise, personalised treatment approaches.

Alpha Tau Medical has completed patient enrolment in its ReSTART trial, assessing the efficacy and safety of Alpha DaRT to treat recurrent cSCC.

Despite a patient death, WhiteSwell is moving forward with its plans to conduct the randomised LYMPH-HF trial on its eLym system in ADHF.

SQ Innovation’s topline data evaluating its Lasix Onyu home care oedema treatment versus SoC IV was shared at the 2026 Heart Failure Congress in Barcelona.

Microsure has secured CE mark approval for its MUSA-3 system and appointed Alex Joseph as its new CEO, taking over from Iwan van Vijfeijken.

Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn.